Governance Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 05/12/2025 GMT			5-day change	1st Jan Change
309.60 ^DKK	+1.24%		-2.33%	-50.40%

12-05	Sector Update: Health Care Stocks Lower Late Afternoon	MT
12-05	Sector Update: Health Care Stocks Decline Friday Afternoon	MT

Executive Committee: Novo Nordisk A/S

Manager

Positions heldSince

Maziar Mike Doustdar

55 year

Chief Executive Officer	06/08/2025
President	06/08/2025

Tania Sabroe

48 year

Human Resources Officer

31/12/2021

Martin Lange

55 year

Chief Tech/Sci/R&D Officer

06/08/2025

Robin Evers

General Counsel

29/02/2024

Karsten Munk Knudsen

54 year

Director of Finance/CFO

14/02/2018

Composition of the Board of Directors: Novo Nordisk A/S

Director

CommitteesSince

Lars Rebien Sørensen

71 year

Chairman

13/11/2025

Stephan Engels

63 year

Compensation Committee	13/11/2025
HR Committee	13/11/2025
Governance Committee	13/11/2025
Audit Committee Chair	13/11/2025

Kasim Kutay

60 year

HR Committee	22/03/2017
Governance Committee	22/03/2017
Compensation Committee	28/01/2024
Nominating Committee	28/01/2024

Cees de Jong

64 year

Audit Committee	13/11/2025
Compensation Committee	28/01/2024
Nominating Committee	28/01/2024
Compensation Committee Chair	13/11/2025

Thomas Rantzau

53 year

HR Committee	21/03/2018
Governance Committee	21/03/2018

Mette Bøjer Jensen

50 year

Audit Committee

28/02/2022

Elisabeth Christensen

60 year

Compensation Committee

23/03/2022

Britt Meelby Jensen

52 year

Audit Committee

13/11/2025

Liselotte Hyveled

59 year

Director/Board Member

23/03/2022

Latest Appointments: Novo Nordisk A/S

12-02	PRESS DIGEST-Canada - Dec 2	RE
11-24	Novo Nordisk says Alzheimer's drug trial fails, hammering shares	RE
11-17	Hims & Hers names ex-FDA official Deb Autor as first policy chief	RE
11-14	Novo Nordisk Elects New Chair, Vice Chair	MT
11-14	Novo Nordisk A/S Approves Board Members	CI
11-14	Novo Nordisk Shareholders Approve New Chair, Board Members -- Update	DJ
11-14	Novo Nordisk Elects New Chair, Vice Chair in Board Shakeup	MT

More news

Former Officers and Directors: Novo Nordisk A/S

Insider

Positions held

SinceUntil

Stig Strøbæk

Director/Board Member

31/12/1997

23/03/2022

Anne Marie Handrup Kverneland

Director/Board Member

31/12/1999

23/03/2022

Mads Krogsgaard Thomsen

Director/Board Member	17/02/2011	08/11/2011
Chief Tech/Sci/R&D Officer	31/10/2000	28/02/2021

Jesper Brandgaard

Director of Finance/CFO	31/10/2000	14/02/2018
General Counsel	14/02/2018	31/03/2019

Göran Albert Ando

Director/Board Member	31/12/2004	19/03/2013
Chairman	19/03/2013	31/12/2017
Chief Tech/Sci/R&D Officer	07/06/2010	07/11/2011

Kåre Schultz

Chief Operating Officer	07/06/2010	29/04/2015
President	31/12/1988	29/04/2015

Hannu Ragnvald Ryöppönen

Director/Board Member	28/02/2009	18/03/2015
Independent Dir/Board Member	15/08/2011	18/03/2015

Lise Kingo

Human Resources Officer	08/11/2011	31/10/2014
Corporate Officer/Principal	07/06/2010	08/11/2011

Sten Scheibye

Chairman	31/12/2002	19/03/2013
Independent Dir/Board Member	31/12/2002	01/05/2012

Per Toft Valstorp

Corporate Officer/Principal

08/07/2009

31/12/2012

Jørgen Wedel

Director/Board Member

31/12/1999

20/03/2012

Pamela Kirby

Director/Board Member

31/12/2007

22/03/2011

Johnny Henriksen

Director/Board Member

23/03/2010

Ulrik Joakim Hjulmand-Lassen

Director/Board Member

29/03/2010

Kurt W. Briner

Director/Board Member

17/03/2009

Peter Gerhardsson

Corporate Officer/Principal

30/04/2008

Niels Jacobsen

Director/Board Member

31/12/1999

31/12/2007

Jan Ulf Sigvar J. Johansson

Director/Board Member

31/12/1997

28/02/2005

Henrik Gürtler

Director/Board Member

31/12/2004

Finn M. Ulrich

Chief Tech/Sci/R&D Officer

31/12/1995

31/12/2003

Robert Frederick Caspari

Corporate Officer/Principal

31/12/2003

Marianne Kock

Corporate Officer/Principal

31/12/1984

31/12/2001

Jack Nielsen

Corporate Officer/Principal

31/12/1989

31/12/2000

Valeta A. Gregg

Corporate Officer/Principal

31/12/1995

31/12/2000

Grethe Nørskov Rasmussen

Corporate Officer/Principal

31/12/1988

Kirsten Drejer

Corporate Officer/Principal

31/12/1990

31/12/1999

Anders Hedegaard

Sales & Marketing

31/12/1990

31/12/1999

Martin Olin

Director of Finance/CFO

31/12/1995

31/12/1999

Thomas Feldthus

Corporate Officer/Principal

31/12/1995

31/12/1998

Christian Hansen

Corporate Officer/Principal

31/12/1991

31/12/1998

Hanne Jensen

Corporate Officer/Principal

31/12/1994

31/12/1998

Jan Öhrström

Sales & Marketing

31/12/1989

31/12/1998

Anker Gunvald Lundemose

Corporate Officer/Principal

31/05/1994

31/10/1998

Peter Nordkild

Corporate Officer/Principal

31/12/1995

Harry Penner

General Counsel	31/12/1984	31/12/1987
Corporate Officer/Principal	31/12/1987	31/12/1992

Carsten Hellmann

Corporate Officer/Principal	31/12/1995	-
Sales & Marketing	31/12/1992	30/12/1995

Leif Kongerslev

Corporate Officer/Principal

31/12/1988

Johan Selmer

Corporate Officer/Principal

31/12/1982

Jørgen Ulrik Vejlsgaard

Corporate Officer/Principal

Torben Nissen

Corporate Officer/Principal

Lotte Sønderbjerg

Corporate Secretary

Mads Fischer Rasmussen

Corporate Officer/Principal

Søren Bregenholt

Chief Investment Officer	08/06/2010	-
Corporate Officer/Principal	-	08/06/2010

Ib Schneider

Corporate Officer/Principal

Kenneth William Harlow

Corporate Officer/Principal

Stephen Farr

Chief Tech/Sci/R&D Officer

Karin Hannader

Corporate Officer/Principal

Niels Jonas Heilskov Graversen

Corporate Officer/Principal

Casper Breum

Corporate Officer/Principal

Thue Walter Schwartz

Chief Tech/Sci/R&D Officer

Mads Dall

Corporate Officer/Principal

Ganesh Iyer

Corporate Officer/Principal

Pál Helmich

Corporate Officer/Principal

Tim Kehling Pedersen

Corporate Officer/Principal

Thomas Lander

Corporate Officer/Principal

Lene Gerlach

Corporate Officer/Principal

Jens Ole Pedersen

Corporate Officer/Principal

Christian Hemmingsen

Corporate Officer/Principal

Jens Morten Fogh

Chief Tech/Sci/R&D Officer

Patrick Michael Round

Corporate Officer/Principal

Claus Kühl

Corporate Officer/Principal

Jaques Arend

Corporate Officer/Principal

Martin O. Andersen

Director of Finance/CFO

Mads Buhl Axelsen

Corporate Officer/Principal

Grith Hagel

Corporate Officer/Principal

Mads Veggerby Lausten

Public Communications Contact

Sam Lindgren

Corporate Officer/Principal

Steen Klysner

Corporate Officer/Principal

Joe A. Young

Sales & Marketing

Jens Frederik Lage Hansen

Sales & Marketing

Mike Rulis

Public Communications Contact

Hans Schambye

Corporate Officer/Principal

Esper Boel

Corporate Officer/Principal

Niels Hvid

Corporate Officer/Principal

Bolette Wildt

General Counsel	-	13/07/2011
Corporate Officer/Principal	13/07/2011	-

Mogens Vang Rasmussen

Corporate Officer/Principal

Anders Pedersen

Corporate Officer/Principal

Michael J. Dwyer

Sales & Marketing

Jakob Dynnes Hansen

Corporate Officer/Principal

Peter W. Ravn

Corporate Officer/Principal

Jeppe Vesti Christensen

Corporate Officer/Principal

Per Bo Pedersen Fischer

Corporate Officer/Principal

Mads Øvlisen

Chairman

Stephan Christgau

Chief Tech/Sci/R&D Officer

Christian Meyer

Corporate Officer/Principal

Henrik Dalbøge

Corporate Officer/Principal

Ole Thastrup

Corporate Officer/Principal

Jürgen Langhärig

Corporate Officer/Principal

Tina Kragh-Jakobsen

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	18
Female	10

Of which Executive Committee

Male	4
Female	1

Of which Directors

Male	5
Female	4

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.6%); - rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).

Employees

78,554

Sector

Pharmaceuticals

Calendar

02-04 - Q4 2025 Earnings Release

More about the company